Latest filing published 24 Feb 2012 for Niagen Bioscience, Inc..
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -9.8%Entry US$2.46 · Close at T+365 US$2.22
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Jeffrey Himmel: trading record in brief
Jeffrey Himmel appears in our data through filings on Niagen Bioscience, Inc. shares, published by SEC (Form 4). We count 3 filings; the first trade dates from 7 February 2012 and the latest from 23 February 2012.
The open-market record is one-sided, with 2 purchases worth €753k and not one sale. The amount is not disclosed for 1 filing. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 1 share grant.
Most recently, on 24 February 2012, the filings show an open-market purchase in Niagen Bioscience, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Jeffrey Himmel
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,000,000 shares0Common Stock, Par Value $0.001 per shareSEC:0001415889-12-000285:0Canonical exit: 23 May 2012 (T+90)
- 1,333,333 shares@ US$0.75Common Stock, Par Value $0.001 per shareSEC:0001415889-12-000232:0Canonical exit: 10 May 2012 (T+90)
- 100,000 shares0Common Stock, Par Value $0.001 per shareSEC:0001415889-12-000177:0
3 of 3 declarations
